A recent memo highlights potential safety risks associated with certain peptides, raising concerns about the future of compounding pharmacies. The discussion reveals that popular substances like BPC 157, known for their healing benefits, could be pushed to unregulated markets if regulations tighten. The pharmaceutical industry's influence is underscored, suggesting a looming shift in how these substances are accessed.
